Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Mesenchymal Stem / Stromal Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem / Stromal Cells (hMSCs)
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

The VEGF‐Mediated Cytoprotective Ability of MIF‐Licensed Mesenchymal Stromal Cells in House Dust Mite‐Induced Epithelial Damage

November 2024 Bioprocessing, Cardiovascular, Cell Therapy, Dermal and Wound, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Orthopedic

The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation

October 2024 Bioprocessing, Cancer, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Lung

Innovative Platforms for Macrophage Behavior: Establishment of Stable Macrophage Reporters And Macrophage-Incorporated Airway Organoid

July 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Dermal and Wound, Gene Editing, Immunomodulation, Lung, Tissue Engineering

Regulation of vascular endothelial integrity by mesenchymal stem cell extracellular vesicles after hemorrhagic shock and trauma

May 2024 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Tissue Engineering

GMP-compliant extracellular vesicles derived from umbilical cord mesenchymal stromal cells: manufacturing and pre-clinical evaluation in ARDS treatment

May 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Tissue Engineering

Mesenchymal Stem Cell Therapy to Rescue Airway Hyperreactivity in a Mouse Model of Neonatal Continuous Positive Airway Pressure

February 2024 Bioprocessing, Cancer, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Lung

Human Macrophage Migration Inhibitory Factor Potentiates Mesenchymal Stromal Cell Efficacy in a Clinically Relevant Model of Allergic Asthma

September 2023 Cell Therapy, Clinical, Immunomodulation, Lung

Refrigerated Human Mesenchymal Stromal Cells as an Alternative to Cryostorage for Use in Clinical Investigation

June 2023 Bioprocessing, Blood, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Lung, Orthopedic

Engineering Hierarchical Vasculature for Regenerative Medicine

May 2023 Bioprinting, Bioprocessing, Blood, Cardiovascular, Cell Therapy, Clinical, Dermal and Wound, Drug Screening, Lung, MedTech, Devices, & Materials, Tissue Engineering

Engineered Mesenchymal Stromal Cell Therapy During Human Lung Ex Vivo Lung Perfusion is Compromised by Acidic Lung Microenvironment

September 2021 Cell Therapy, Lung, MedTech, Devices, & Materials
1 2 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Mesenchymal Stem / Stromal Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2025 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email